Clinical Trials Browser

Phase 2 × emvododstat × CNS × Clear all

NCT00911248 2019-04-12

PTC299 for Treatment of Neurofibromatosis Type 2

Phase 2 Terminated

Neurofibromatosis 2, Neurofibromatoses